Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women’s health and prostate cancer designed to improve the lives of millions. We are on a mission to develop and deliver empowering medicines for women’s health and prostate cancer through purpose-driven science and transformative advocacy. We are looking for passionate and hard-working individuals who share our excitement for this mission.

Summary Description

We are currently seeking a dynamic, highly motivated, experienced individual for the position of Director/Senior Director, Clinical Pharmacology. The position reports to the Vice President, Early Clinical Development.  The location of the position is in Brisbane, CA but flexibility is possible for the right candidate.

The Clinical Pharmacology Director/Senior Director will be responsible for the development of the strategic, scientific, translational and clinical aspects of a clinical pharmacology development plan, including defining key milestones and decisions, identifying risks and mitigation strategies, study planning and execution, providing input to modeling and simulation plans and the interpretation of pharmacokinetic, pharmacokinetic and safety data from phase 1 studies and ensure alignment and seek input from cross-functional partners, consultants, experts and vendors as necessary; lead author and contributor to relevant sections of regulatory documents including IND or IMPD submissions, briefing packages or background documents and NDA or MAA submissions;  serve as the study director and/or medical monitor for all phase 1 to phase 2a studies, as necessary, including first-in-man, biopharmaceutics, drug-interaction, special populations and proof-of-pharmacology/concept studies;  and provide functional representation at project team meetings and during regulatory interactions.

Essential Duties & Responsibilities

Early Development/Clinical Pharmacology Studies:

  • Act as Medical Monitor/ Study Director to collaborate with internal and external cross-functional study team members, provide scientific and clinical/medical input into the rationale and design, procedures and safety assessment requirements for early development/clinical pharmacology (phase 1 to phase 2a) studies and phase 3 studies
  • Contribute to the appropriate use of biomarkers in early development studies with a focus on endocrinology
  • Collaborate with the operations lead, provide oversight of early development studies during study execution and serve as the study medical monitor to ensure all studies are safely conducted with the utmost scientific integrity
  • Participate in the identification and the evaluation of clinical trial sites and CROs,
  • Provide subject matter expertise to the interpretation of pharmacokinetic and pharmacodynamic data for proper data interpretation and reporting, including co-authoring, review and finalization of clinical study reports

Early Development functional expertise and organizational excellence:

  • Responsible for preparation of early clinical development plans (program-level) and effectively liaise with key partner line functions to identify potential project hurdles, provide solutions and contribute to contingency plans,
  • Contributor to the preparation of early clinical development components of regulatory documents, including INDs, IMPDs, CTAs, Investigator Brochures and responsible for authoring and finalization of biopharmaceutics and clinical pharmacology modules and subsections of other modules, as appropriate, of NDA and MAA submissions,
  • Attend meetings with external stakeholders (investigators, KOLs) and health authorities, as necessary,
  • Serve as early development functional representative on project teams
  • Contribute to the evaluation of licensing-in opportunities with a focus on endocrinology and women’s health
  • Actively participate in internal workstreams and cross-functional or cross-departmental initiatives to improve department working standards.

Core Competencies, Knowledge and Skill Requirements

  • Excellent working knowledge of clinical pharmacology (pharmacokinetics, pharmacodynamics, translational medicine) and drug development principles
  • Ability to interpret and communicate complex scientific concepts in a concise and clear manner to an audience with various levels of expertise to ensure scientific input is incorporated into strategic decision-making
  • Good working knowledge of FDA, EMA and ICH regulations and ability to incorporate relevant regulatory requirements into development plans, study design and ensure adherence to regulations, including GCP requirements during study conduct
  • Direct experience leveraging modeling and simulation to facilitate compound development and registration with a good understanding of the technical aspects of modeling and available software used for analysis
  • Demonstrate communication and collaboration skills with an ability to manage and influence stakeholders in a matrix environment effectively
  • Exercise good judgment and make decision that is appropriate for the organization
  • Results-driven, take initiative and ownership to accomplish work
  • Ability to demonstrate flexibility and embrace change in a dynamic, rapidly growing environment
  • Strive for continuous improvement and embrace innovative ideas in daily work
  • Thought leader with track record to formulate and integrate functional strategies with corporate objectives and translate them into actionable deliverables.
  • High degree of organizational awareness, ability to connect the dots to understand all the interdependency and big picture

REQUIREMENTS

Education, Experience and Training 

  • MD, PharmD, and/or PhD in clinical pharmacology.
  • Minimum 15+ years of previous industry experience in early clinical development and/or clinical pharmacology with a proven track record regarding the development and/or contribution to an early clinical development/clinical pharmacology development plan, accountability for the scientific, clinical and operational aspects of phase 1 studies including completion of the CSR and contribution to regulatory interactions, documents and/or submissions is preferred.
  • A completed residency program (clinical pharmacology program) and/or a post-doctoral fellowship is desired.

Disclaimer: The above statements are intended to describe the general nature and level of work being performed by people assigned to this classification. They are not to be construed as an exhaustive list of all responsibilities, duties, and skills required of personnel so classified. All personnel may be required to perform duties outside of their normal responsibilities from time to time, as needed.

Equal Employment Opportunity

Apply for this Job

* Required
  
  


U.S. Equal Opportunity Employment Information (Completion is voluntary)

Individuals seeking employment at Myovant Sciences are considered without regards to race, color, religion, national origin, age, sex, marital status, ancestry, physical or mental disability, veteran status, gender identity, or sexual orientation. You are being given the opportunity to provide the following information in order to help us comply with federal and state Equal Employment Opportunity/Affirmative Action record keeping, reporting, and other legal requirements.

Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.


Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

1Section 503 of the Rehabilitation Act of 1973, as amended. For more information about this form or the equal employment obligations of Federal contractors, visit the U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.